89 related articles for article (PubMed ID: 919806)
21. [A clinico-pathogenetic approach to choosing the therapeutic procedure in chronic glomerulonephritis].
Tov NL; Sidorova LD; Valentik MF; Movchan EA; Savitskaia IV; Nekipelova VI; Dorofeev SB; Nesina IA
Ter Arkh; 1990; 62(6):37-42. PubMed ID: 2218924
[TBL] [Abstract][Full Text] [Related]
22. [Effects of pathogenetic therapy on blood cholesterol in patients with glomerulonephritis].
Neverov NI; Stavrovskaia EV; Kolina IB; Shvetsov MIu; Zakharova EV; Shilov EM
Ter Arkh; 2001; 73(6):37-40. PubMed ID: 11521519
[TBL] [Abstract][Full Text] [Related]
23. [Treatment of glomerulonephritis].
Scholz D; Natusch R
Z Gesamte Inn Med; 1976 Jun; 31(22):450-7. PubMed ID: 969777
[TBL] [Abstract][Full Text] [Related]
24. [Preliminary report on the effects of immunosuppressive therapy with azathioprine in glomerulonephritis].
Castellani A; Romagnoli GF; Rizzo A; Borsatti A; Gambari PF; Campanacci L
Minerva Nefrol; 1968; 15(4):219-35. PubMed ID: 5745810
[No Abstract] [Full Text] [Related]
25. Therapy of proliferative lupus glomerulonephritis: a prospective trial in The Netherlands.
van den Wall Bake AW; Berden JH; Derksen RH; de Glas-Vos JW; Hagen EC
Neth J Med; 1994 Dec; 45(6):280-4. PubMed ID: 7838244
[TBL] [Abstract][Full Text] [Related]
26. [Comparison of two cyclophosphamide treatment regimens in nephrotic patients with chronic glomerulonephritis].
Krasnova TN; Shilov EM; Tareeva IE; Gordovskaia NB; Lavrova ON; Miroshnichenko NG; Troepol'skaia OV; Ivanova LV; Ivanov AA
Ter Arkh; 1998; 70(6):14-7. PubMed ID: 9695216
[TBL] [Abstract][Full Text] [Related]
27. [Results of the treatment of mesangiocapillary glomerulonephritis].
Rodríguez JA; Olmos A; Ferrer E; Mauri JM; Capdevilla L; Codina S; Alsina J; Camps J; Piera L
Rev Clin Esp; 1975 Dec; 139(5):415-22. PubMed ID: 1215585
[No Abstract] [Full Text] [Related]
28. [Treatment of membranous glomerulonephritis].
Stavskaia VV; Riabov SI
Ter Arkh; 1985; 57(6):74-8. PubMed ID: 4071419
[TBL] [Abstract][Full Text] [Related]
29. [Attempts of the use of cytostatic agents in some forms of glomerulonephritis in children].
Nowak S; Bodalski J; Margolis A; Michalak A
Pediatr Pol; 1969 May; 44(5):549-60. PubMed ID: 5791319
[No Abstract] [Full Text] [Related]
30. [Possibilities for treating patients with the idiopathic nephrotic syndrome].
Belovezhdov N
Vutr Boles; 1985; 24(4):55-63. PubMed ID: 4072170
[TBL] [Abstract][Full Text] [Related]
31. The effects of azathioprine and prednisolone on T- and B-lymphocytes in patients with lupus nephritis and chronic glomerulonephritis.
Tareyeva IE; Shilov EM; Gordovskaya NB
Clin Nephrol; 1980 Nov; 14(5):233-7. PubMed ID: 6971722
[TBL] [Abstract][Full Text] [Related]
32. Long-term treatment and prognosis of rapidly progressive glomerulonephritis.
Keller F; Oehlenberg B; Kunzendorf U; Schwarz A; Offermann G
Clin Nephrol; 1989 Apr; 31(4):190-7. PubMed ID: 2714023
[TBL] [Abstract][Full Text] [Related]
33. Comparative observations in the treatment of acute leukaemia.
Gráf F; Fekete S; Benedek S; Sréter L; Takácsi-Nagy L
Haematologia (Budap); 1976; 10(1):81-7. PubMed ID: 1070470
[TBL] [Abstract][Full Text] [Related]
34. Rapidly progressive glomerulonephritis with extensive crescents.
Cameron JS; Ogg CS
Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):735-8. PubMed ID: 4807809
[No Abstract] [Full Text] [Related]
35. [Treatment of primary chronic glomerulonephritis with a triple combination of prednisone, azathioprine and a nitrogen mustard derivative].
Traver JA; Guajardo DS; Botella J
Rev Clin Esp; 1975 May; 137(4):321-5. PubMed ID: 1144863
[No Abstract] [Full Text] [Related]
36. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
Duman VL; Shkerina LI; Shilov EM
Klin Med (Mosk); 2005; 83(10):48-50. PubMed ID: 16320847
[TBL] [Abstract][Full Text] [Related]
37. [ANCA-associated vasculitis].
Sinico RA; Sabadini E; Boeri R; Radice A
G Ital Nefrol; 2002; 19(2):125-36. PubMed ID: 12195410
[TBL] [Abstract][Full Text] [Related]
38. Treatment of glomerulonephritis (GN) with anticoagulants (AC), immunosuppressors (IS) and corticosteroids (CS).
Belovezhdov N; Altunkova I
Przegl Lek; 1985; 42(4):416-8. PubMed ID: 4048531
[No Abstract] [Full Text] [Related]
39. [Prolonged treatment of mesangioproliferative glomerulonephritis with a cytostatic agent and prednisolone and a combination of a cytostatic agent, prednisolone an anticoagulant and an antiaggregant].
Ratner MIa; Tomilina NA; Klinkman Kh; Shmitt E; Kreger E
Ter Arkh; 1980; 52(8):106-10. PubMed ID: 7256574
[No Abstract] [Full Text] [Related]
40. Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide.
Mok CC; Ying KY; Ng WL; Lee KW; To CH; Lau CS; Wong RW; Au TC
Am J Med; 2006 Apr; 119(4):355.e25-33. PubMed ID: 16564783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
